Jeffrey M. Leiden
Executive Chairman at Vertex Pharmaceuticals Incorporated
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Vertex Pharmaceuticals Incorporated, 3 years.
Vertex Pharmaceuticals Incorporated
Director · Executive Chairman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 14, 2025 | Vertex Pharmaceuticals Incorporated | Shares withheld for tax | −6,066 | $463.46 | $2,811,348 |
| Feb 13, 2025 | Vertex Pharmaceuticals Incorporated | Shares withheld for tax | −2,525 | $450.83 | $1,138,346 |
| Feb 12, 2025 | Vertex Pharmaceuticals Incorporated | Grant or award | +7,209 | — | — |
| Feb 4, 2025 | Vertex Pharmaceuticals Incorporated | Grant or award | +15,414 | — | — |
| Aug 30, 2024 | Vertex Pharmaceuticals Incorporated | Open-market sale | −3,784 | $499.00 | $1,888,216 |
| Feb 20, 2024 | Vertex Pharmaceuticals Incorporated | Shares withheld for tax | −4,118 | $420.58 | $1,731,948 |
| Feb 15, 2024 | Vertex Pharmaceuticals Incorporated | Open-market sale | −4,655 | $419.16 | $1,951,190 |
| Feb 14, 2024 | Vertex Pharmaceuticals Incorporated | Open-market sale | −4,356 | $419.04 | $1,825,338 |
| Feb 13, 2024 | Vertex Pharmaceuticals Incorporated | Open-market sale | −737 | $419.13 | $308,899 |
| Feb 12, 2024 | Vertex Pharmaceuticals Incorporated | Open-market sale | −2,009 | $419.22 | $842,213 |
| Feb 12, 2024 | Vertex Pharmaceuticals Incorporated | Open-market sale | −647 | $420.39 | $271,992 |
| Feb 9, 2024 | Vertex Pharmaceuticals Incorporated | Shares withheld for tax | −8,048 | $422.74 | $3,402,212 |
| Feb 8, 2024 | Vertex Pharmaceuticals Incorporated | Shares withheld for tax | −2,698 | $421.73 | $1,137,828 |
| Feb 7, 2024 | Vertex Pharmaceuticals Incorporated | Grant or award | +7,707 | — | — |
| Feb 6, 2024 | Vertex Pharmaceuticals Incorporated | Grant or award | +10,464 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.